Universal Health's stock plummeted 5.51% during intraday trading on Tuesday, reflecting significant selling pressure.
The sharp decline followed news that Barclays cut its target price for Universal Health Services Inc. to $238 from $268, indicating reduced analyst confidence in the company's near-term prospects.